SCHEMBL2889663

SCHEMBL2889663

c1ccc(Sc2ccc3[nH]ccc3c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.56
AHR P35869 4/20 0.48
TRPA1 O75762 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
ITGB2 P05107 1/20 0.48
ICAM1 P05362 1/20 0.48
ITGAL P20701 1/20 0.48
CA4 P22748 1/20 0.48
CA6 P23280 1/20 0.48
ADK P55263 1/20 0.48
NR4A2 P43354 2/20 0.47
CYP2A6 P11509 2/20 0.47
F7 P08709 1/20 0.47
LTA4H P09960 1/20 0.47
F3 P13726 1/20 0.47
USP2 O75604 1/20 0.47
GAA P10253 1/20 0.47
ALOX15 P16050 1/20 0.47
RAD51 Q06609 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4806892 0.79 MEN1 (0.54) AHRNR4A2CYP2A6F7LTA4H
SCHEMBL28061060 0.79 IDO1 (0.50) MAOAMAOBSLC6A2SLC6A4SLC6A3
SCHEMBL29336860 0.79 IMPDH2 (0.63) NPC1AHRNR4A2CYP2A6F7
SCHEMBL8869328 0.76 L3MBTL1 (0.50) NPC1AHRTRPA1CA1CA2
SCHEMBL29336862 0.76 F2 (0.65) NPC1USP2GAAALOX15RAD51
SCHEMBL2942909 0.75 AHR (0.54) NPC1AHRTRPA1CA1CA2
SCHEMBL6090445 0.74 TUBB4A (0.48) NPC1AHRNR4A2CYP2A6F7
SCHEMBL5134026 0.74 AHR (0.52) NPC1AHRTRPA1CA1CA2
SCHEMBL446619 0.72 NPC1 (1.00) NPC1AHRTRPA1CA1CA2
SCHEMBL21480346 0.72 PLA2G1B (0.61) AHRMAOAMAOBMAPTPLA2G1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7683218-B2 Method for producing thioether compound BANYU PHARMACEUTICAL CO., LTD. (JP) 2010-03-23 US disclosed
US-7683218-B2 Method for producing thioether compound BANYU PHARMACEUTICAL CO., LTD. (JP) 2010-03-23 US disclosed
US-7683218-B2 Method for producing thioether compound BANYU PHARMACEUTICAL CO., LTD. (JP) 2010-03-23 US disclosed
US-20080108823-A1 Method For Producing Thioether Compound MSD K.K. (JP) 2008-05-08 US disclosed
US-20080108823-A1 Method For Producing Thioether Compound MSD K.K. (JP) 2008-05-08 US disclosed
US-20080108823-A1 Method For Producing Thioether Compound MSD K.K. (JP) 2008-05-08 US disclosed
EP-1806337-A1 METHOD FOR PRODUCING THIOETHER COMPOUND BANYU PHARMACEUTICAL CO., LTD. (JP) 2007-07-11 EP disclosed
EP-1806337-A1 METHOD FOR PRODUCING THIOETHER COMPOUND BANYU PHARMACEUTICAL CO., LTD. (JP) 2007-07-11 EP disclosed
US-5637593-A MIGRAINE; HYPOTENSIVE AGENTS SMITHKLINE BEECHAM PLC (GB) 1997-06-10 US disclosed
EP-0674619-A1 TRYPTAMINE ANALOGUES AS 5-HT 1?-LIKE AGONISTS SMITHKLINE BEECHAM PLC (GB) 1995-10-04 EP disclosed
WO-1994014770-A1 TRYPTAMINE ANALOGUES AS 5-HT1-LIKE AGONISTS SMITHKLINE BEECHAM PLC (GB) 1994-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108823-A1 Method For Producing Thioether Compound TST, MPST, PPIP5K2 NPC1 3856/4885AHR 2207/4885TRPA1 2202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.